Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000629173 | SCV000750089 | pathogenic | Hypertrophic cardiomyopathy | 2018-05-02 | criteria provided, single submitter | clinical testing | This variant is an out-of-frame deletion of the genomic region encompassing exons 23-26 of the MYBPC3 gene. This is expected to create a premature translational stop signal and result in an absent or disrupted protein product. A similar variant has been reported in individuals affected with hypertrophic cardiomyopathy (PMID: 27532257, 22115648). Loss-of-function variants in MYBPC3 are known to be pathogenic (PMID: 19574547). For these reasons, this variant has been classified as Pathogenic. |